CE Credit

Genetic Screening, Testing, Treatment, and Referral

""

Welcome to the training on Genetic Screening, Testing, Treatment, and Referral provided by the Texas Department of State Health Services (DSHS) and the Texas Health and Human Services Commission (HHSC).

Credit hours: 1.25 CE

Goal

The goal of this module is to educate physicians and other health-care professionals about best practices and ethical guidelines for genetic clinical evaluations, screening and testing, appropriate referrals, and ongoing care in a primary care practice.

Target Audience

Texas Health Steps providers and other interested health-care professionals.

Specific Learning Objectives

After completing the activities of this module, you will be able to:

  1. Specify how to use genetic information to help patients at risk for disease.
  2. Using American Academy of Pediatrics (AAP) guidelines, determine when it is ethically appropriate to refer a child for predictive genetic testing.
  3. Specify one pediatric condition and one adolescent/adult condition that may require genetic evaluation.
  4. Evaluate a criterion for assessing unusual physical features that may need to be evaluated by a geneticist.
  5. Plan follow-up care after a genetic referral has been made.
  6. Determine the value of obtaining a detailed family history.
  7. Summarize the benefit of using trained medical interpreters when interpreting services are needed to obtain a family history.
  8. Assess the value of a clinical geneticist in collaboration with a primary care provider.
  9. Review three diagnostic activities that are typically included in an initial genetic consultation.
  10. Employ two online resources for locating a genetic professional in Texas.

Please note this module expires on 2/6/2018.

Accreditation Statement

Disclosures

  • Pagon, R. A., Adam, M. P., Ardinger, H. H., Bird, T. D., Dolan, C. R., Chin-To, F., … & Stephens, K. (Eds.). (1993-2014). GeneReviews® [Internet]. Seattle, WA. University of Washington, Seattle.

The medical definitions in this module were obtained or adapted from the International 22q11.2 Foundation, Inc., the International Rett Syndrome Foundation, the March of Dimes, the Mayo Clinic, Medicaid, the National Institute of Neurological Disorders and Stroke in the National Institutes of Health, the Prader-Willi Syndrome Association, and the U.S. National Library of Medicine.